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Determining an appropriate control for use in acupuncture research remains one of the largest methodological challenges
acupuncture researchers face. In general, acupuncture controls fall under one of two categories: (1) sham acupuncture, in which
the skin is punctured with real acupuncture needles either fully at nonacupoint locations or shallowly at acupoint locations or both
and (2) placebo acupuncture, which utilizes nonpenetrating acupuncture devices. In this study, we will focus on non-penetrating
placebo acupuncture devices (blunted-needle and nonneedle devices) that are currently available in acupuncture research. We
will describe each device and discuss each device’s validation and application in previous studies. In addition, we will outline the
advantages and disadvantages of these devices and highlight how the differences among placebo devices can be used to isolate
distinct components of acupuncture treatment and investigate their effects. We would like to emphasize that there is no single
placebo device that can serve as the best control for all acupuncture studies; the choice of an acupuncture control should be
determined by the specific aim of the study.
1. Introduction
Over the past decades, acupuncture treatment has gained
popularity in the Western world due to its therapeutic
effect. However, studies have achieved contradictory results
when using control treatments to test the true efficacy of
acupuncture. Studies consistently show that both real and
placebo acupuncture treatments confer significant benefits
over no-treatment control conditions [1, 2], and while some
studies have suggested that real acupuncture is significantly
more effective than placebo acupuncture [3–5], others have
failed to demonstrate the benefit of real acupuncture over
placebo acupuncture [6–9]. Although the reasons for such
contradictory results remain unclear, these results call for fur-
ther investigation of sham/placebo controls in acupuncture
research.
Placebo research has revealed several important variables
related to acupuncture treatment that can be either mod-
ulated or held constant between verum (real) and placebo
(control) conditions in order to test the effects of specific
and nonspecific components of acupuncture. In general,
acupuncture involves the insertion of needles into the body;
thus, one of the components of verum acupuncture is skin
penetration.While this particular component is not held con-
stant between verum and non-penetrating acupuncture con-
trols, there are several other variables that can be either held
constant or modulated, which include sensory stimulation,
dose (number of needles), acupoint location, practitioner-
patient interaction, and treatment setting.
In acupuncture research, double-blinded randomized
clinical trials (RCTs) serve as the gold standardwhen compar-
ing the effects of a specific treatment to the effects of a placebo
control. In acupuncture RCTs, it is ideal for the control treat-
ment to be both physiologically inert and indistinguishable
from the real treatment. Thus, an effective inert treatment
in the control condition is essential in order for a double-
blinded RCT to achieve a high level of scientific validity.
Determining the proper inert control for an RCT designed
to evaluate the efficacy of acupuncture is methodologically
challenging for three main reasons.
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(1) It is difficult to create an inert control device that
mimics both the visual appearance of the acupuncture
treatment device and the method of needle insertion
involved in acupuncture treatment.
(2) It is challenging to develop an inert acupuncture
device that can control for all nonspecific factors
involved in an acupuncture treatment. The therapeu-
tic effect of acupuncture relies on several nonspecific
factors, including the ritual procedure of acupuncture
administration, the patient-practitioner interaction,
the nature of the illness, the treatment, and the treat-
ment setting [10]. The microtrauma resulting from
piercing the skin also induces a variety of nonspecific
physiological responses involving the microcircula-
tion, local immune function, and neurally mediated
analgesic effects [11, 12].
(3) It is challenging to make the acupuncturist who
is directly administrating the acupuncture blind to
treatment condition.
As a result, over the years, investigators have used a vari-
ety of controls in their studies to account for these challenges
in terms of their own specific study aims. In acupuncture
research, placebo controls for acupuncture studies fall under
one of two categories: (1) sham acupuncture, in which the
skin is punctured with real acupuncture needles either fully
at nonacupoint locations or shallowly at acupoint locations,
or both and (2) placebo acupuncture, which utilizes non-
penetrating acupuncture devices. In this review, we will
focus only on non-penetrating placebo acupuncture devices,
including blunted needle and nonneedle devices that are
currently available for use in acupuncture research.
2. Placebo Acupuncture Devices
2.1. Blunted Needle Acupuncture Devices
2.1.1. The Streitberger Device
Description. In 1998, Streitberger andKleinhenz [13] designed
a blunted-needle placebo device, comprised of a copper
handle and a stainless steel needle with a blunt tip designed
to retract inside the handle (Figure 1). When the blunt tip is
pressed against the skin, the patient feels a slight pricking
sensation, which mimics the sensation elicited by a verum
needle but does not actually puncture the skin. As the blunt
tip is pressed onto the skin, the needle retracts into the
handle, creating the appearance of penetration. This device
is anchored in a plastic ring on the skin surface and held in
place with surgical tape or plaster.
Validation/Application. The results from the first vali-
dation study of the Streitberger device [13] indicate that
subjects in this study could not differentiate between verum
acupuncture and the Streitberger device. In this crossover
study, 60 healthy subjects, blinded to treatment condition,
were asked to evaluate subjective ratings of acupuncture
sensations using a visual analog scale (VAS) after both the
placebo and verum acupuncture treatment.
Plastic ring Plastic cover
Placebo
Skin surface
Verum
Figure 1: The Streitberger device. The Streitberger placebo device
uses a short blunt needle within a thin handle. A plastic ring covered
with a plastic sheath is used to keep the needle in place.
Subsequently, the Streitberger device has been used as
a control in acupuncture research [14–21] and clinical trials
covering a range of indications [22, 23], resulting in a
variety of findings. After the initial crossover experiment,
Streitberger and colleagues conducted several trials in other
clinical populations, the results of which indicated that
the true efficacy of acupuncture may be specific to certain
ailments [24]. For example, the investigators found verum
acupuncture to be slightly more effective (𝑃 = .07) than
placebo acupuncture in relieving postoperative nausea and
vomiting prophylaxis in patients undergoing gynecological
surgery but not for those undergoing breast surgery (𝑃 =
.86) [24]. Results from another RCT conducted by Schneider
and colleagues [25] suggest that the efficacy of acupuncture
treatment for irritable bowel syndrome is primarily a placebo
response. In one randomized trial [26], 52 males with rotator
cuff tendinitis underwent 4 weeks of treatment, either with
penetrating (verum) or non-penetrating (the Streitberger
device) acupuncture, and were asked to rate their pain using
the modified Constant-Murley shoulder outcomes scale
(including pain, function, range of motion, and strength).
The verum acupuncture group showed significantly more
improvement in subjective pain ratings compared to the
placebo acupuncture control.
2.1.2. Park Device
Description. Park and colleagues [27] invented a placebo
device intended to stabilize the needle (either penetrating or
blunted) in positionwith an additional plastic tube (Figure 2).
The Park device consists of two tubes. The guide tube holds
the needle perpendicular to the skin and is fitted within
the Park tube, a larger tube fixed to the ring base, so that
the standard guide tube slides freely within the Park tube.
A silicon base rests under the ring base and adheres to the
skin with double-sided tape. The acupuncturist positions the
needle perpendicular to the skin and taps the handle of
the needle in a precise imitation of the insertion of a real
acupuncture needle. When a verum needle is used within
the Park device, the needle is long enough to penetrate the
skin. A placebo needle, in contrast, is too short to penetrate
the skin through the Park device. After positioning the
needle it may then be manipulated by lifting, thrusting, or
rotating.
Unlike the Streitberger device, the Park device includes
a Park tube that holds the placebo needle more firmly in
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Guide tube
Park tube
Ring base
Figure 2: The Park device. The Park device is a placebo device that
employs an oversize guide tube. The device adheres to the skin
with double-sided tape. A second guide tube providesmore stability,
sliding to fit within the Park tube.
place and facilitates lifting and thrusting, a common manual
stimulation technique in acupuncture. Due to the fact that the
guide tube is fixed to the skin, the Park device cannot be used
to insert the needle at certain angles or depths.This limitation
is problematic when using acupoints requiring shallow or
horizontal insertion.
Validation/Application. The Park device was validated in
two separate studies by Park and colleagues in 2002 [28].
The first study involved 58 acute stroke patients and the
second involved 63 healthy acupuncture-naive volunteers.
The purpose of these validation studies was to test the
Park device in both a patient population and in healthy
volunteers (aged 16 years and older) in order to assesswhether
the device was indistinguishable from verum acupuncture
(study 1) and whether the device was “active” (i.e., whether
it elicited sensations (deqi) specific to the needling action)
when applied at the Hegu (LI4) point (study 2). The results
of this RCT suggested that the Park device was both “indis-
tinguishable” and “inactive” when employed. But there are
some problems when using the Park device. For example,
it may be more difficult to maintain participant blinding
when using the Park device on traditional acupoints com-
pared to nontraditional acupuncture points [29], or on the
upper limb (i.e., Triple Energizer Meridian) acupoints com-
pared to the lower limb acupoints (i.e., Bladder Meridian)
[30].
Since the original validation studies, the Park device
has been used in several acupuncture RCTs as a placebo
acupuncture control [31–34]. For instance, in one RCT
[35], the authors compared the efficacy of verum acupunc-
ture (56 stroke patients) and the Park device (60 stroke
patients) and they found that verum acupuncture was
not superior to placebo treatment in terms of improve-
ments in health-related quality of life after suffering a
stroke.
Stopper
Needle
Upper stuffing
Opaque guide tube
Lower stuffing
Pedestal
Figure 3: The Japanese device. The Japanese device is comprised of
an opaque guide tube and an upper stuffing. The stopper prevents
the needle handle from advancing further. In addition, the placebo
contains stuffing at the bottom to provide a sensation similar to that
of skin puncture and tissue penetration.
2.1.3. Japanese Device
Description. The Japanese device, which employs a non-
penetrating placebo needle (Figure 3), was designed by
Takakura and Yajima for use in double-blind trials [36]. Like
the needle of the Park and Streitberger devices, the tip of the
placebo needle in the Japanese devicemakes non-penetrating
contact with the skin. The Japanese device can be used with
both verumandplaceboneedles and blinding of both patients
and acupuncturists can bemaintained. To our knowledge, the
Japanese device is the only needle device that can maintain
both patient’s and acupuncturist’s blinding. The verum and
placebo needles used in the Japanese device differ in length.
When a placebo needle is employed, the presence of the
lower stuffing provides a substrate into which the needle
can be inserted. When the verum needle is used, the sharp
tip penetrates the skin. Inserting the needle into the lower
stuffing of the placebo device produces a sensation similar
to the sensation of skin being punctured for the patient and
the sensation of tissue penetration for the acupuncturist,
which allows both patient and acupuncturist to remain
blinded to treatment condition. Both needles have a stopper
that prevents the needle handle from advancing beyond the
specified position of the penetrating needle or the non-
penetrating needle. Due to fixed needle length and stuffing
position, the Japanese device, like the Park device, is restricted
in its ability to simulate traditional needle manipulation
methods and various angles of insertion.This device requires
custom manufacturing. Currently, it is only available for use
by the inventor-investigators and awaits validation by other
clinical trials.
Validation/Application. Investigations of the validity of the
Japanese device suggest that it is quite indistinguishable from
4 Evidence-Based Complementary and Alternative Medicine
Placebo
Foam
Skin surface
Verum
Figure 4: Foam device.The foam placebo (one example shown here)
device uses a blunted needle inserted through a piece of elastic foam.
a verum device. In one study, the authors found that both
experienced acupuncturists and acupuncture-experienced
subjects made statistically equal numbers of correct and
incorrect judgments of needle type (verum or Japanese
device) after administration of treatments [37]. In another
study, practitionersmademore incorrect judgments than cor-
rect judgments [38] suggesting that this device was effective
at maintaining practitioner’s blinding.
2.1.4. Foam Device
Description. There are several versions of the foam device
used for placebo acupuncture treatment (see Figure 4 for one
example).This device involves the use of a blunted needle and
a cube of elastic foam for needle positioning.The acupunctur-
ist must first fix the foam on a specified acupoint. In contrast
to the verum acupuncture device, inwhich the sharp needle is
inserted into skin through the foam, the placebo device holds
the blunted needle within the foam. Compared with other
devices, the foam device is simple and inexpensive. There
are many variations of this device, so the specific design of
the device must be taken into consideration. The Goddard
device [39], for example, has no needle stopper, so it is
the acupuncturist’s responsibility to stop pushing the needle
when s/he perceives that the placebo needle has touched the
skin. Similarly, other foam devices require the acupuncturist
to be careful during needle rotation not to advance the needle
too far, in order to avoid skin contact entirely [40]. For
all of the foam devices, the foam pad visually conceals the
needle’s point of entry, so that the subject cannot discern
which technique is being used; it also helps to hold the needle
in place so that it appears identical to real acupuncture needle
positioning.
Validation/Application. In one randomized single-blind val-
idation study, 49 healthy subjects were divided into two
treatment groups: acupuncture group and placebo group.
Goddard and colleagues [39] demonstrated that subjects
were not able to differentiate between verum and placebo
acupuncture. Placebo acupuncture was conducted by lightly
pricking the skin with a shortened, blunted acupunc-
ture needle through a foam pad, without penetrating the
skin.
In a study of 36 rheumatoid arthritis patients conducted
by Tam and colleagues [40], investigators adhered a standard
cube of foammaterial (2 cm× 2 cm× 2 cm) to the skin around
the acupoint visible to patients. The recipient could not see
the depth of the needle since the cube of foam hid the tip of
the needles.
In another validation study using a crossover design [41],
32 healthy volunteers were randomly first assigned to either a
verum acupuncture group or a placebo acupuncture group.
After 30 minutes, the subjects received another modality
of treatment. The main outcome measurement was a self-
report questionnaire of deqi sensations. In this study, an
adhesive patch made of two pieces of high-density foam,
13mm in length, 5mm in height, and 12.7mm in width
was perforated in order to hold a needle guidance tube.
The guide tube sufficiently masked the needle from view
such that subjects were not able to determine whether they
were receiving real or placebo acupuncture when the patch
was placed on the skin. In this study, a shortened needle
with a blunted tip was used in order to avoid pricking
the skin after tapping the needle. In this crossover study,
there were no significant differences in ability to differentiate
between the real and placebo needles before or after subjects
received their second acupuncture condition. These results
suggest that this method is credible for the subjects and
constitutes a simple, inexpensive technique in use as a control
in clinical research with a population of acupuncture-naive
subjects.
2.1.5. Other Nonpenetrating Needle Devices
Description. Multiple investigators have designed their own
noninvasive needle-delivering apparatuses using blunted
needles, toothpicks, or plastic guide tubes. These devices
are simple, easy to manipulate, and do not require extra
equipment. These control devices are designed to be as
effective, inert, and indistinguishable as the devices that have
preceded them; however, they do not mimic the appearance
of the verum acupuncture devices with regard to needle
insertion and therefore must be kept outside of the subject’s
visual range. They can be applied to the neck, back, and
any other body region that the subject cannot see. If visible
acupoints must be targeted, subjects’ eyes must be covered to
prevent unblinding.
Application. The blunted needle device employs a needle,
with the tip removed. The blunt tip of this specialized needle
prevents the needle from penetrating the skin. The cut
ends are manually smoothed with sandpaper under sterile
conditions. The acupuncturist mimics needle insertion by
applying the sparrow pecking technique (i.e., rapid stimu-
lation of a single acupoint with the blunt tip of the needle)
[4, 42].
Plastic guide tubes are also used as placebo devices, as
they provide the sensation of acupuncture stimulation but do
not penetrate the skin [43].The plastic guide tube can also be
combined with a blunted needle or toothpick to further pro-
vide the sensation of acupuncture stimulation [3, 7, 44–47].
Trials involving these devices are difficult to replicate
because the devices are not standardized. Since the majority
of these trials have not been precisely replicated (i.e., the
devices are slightly different), the validity of the results of
RCTs that use these devices remains to be tested.
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2.2. Nonneedle Acupuncture Devices
2.2.1. Transcutaneous Electrical Nervous Stimulation (TENS)
Description. Transcutaneous electrical nerve stimulation
(TENS) is the application of a mild electrical current to
the cutaneous nerve fibers using surface electrodes. It is
characterized by current, pulse width, and frequency. The
amplitude of the current is usually adjusted to just above or
below sensory threshold. The duration of stimulation varies
from a short period of time (e.g., 20 minutes) to continuous
stimulation (e.g., 60 minutes or even longer). The placebo
TENS device uses a nonfunctional TENS apparatus with no
electrical stimulation. While the efficacy of verum TENS
remains unknown, the placebo TENS device is an example
of a double-blind placebo device that can act as a control to
estimate the efficacy of the verum device because it is visu-
ally indistinguishable from the verum device. TENS differs
entirely from needle acupuncture and thus the placebo TENS
device may best serve as a control for verum TENS trials.
A new variation of TENS device worth noting is a special
electrode designed for ear stimulation. It consists of two
pair carbon-impregnated silicone electrodes fixed to one ear
clamp; only one pair of the electrodes is connected to the
electrical wire. Given that the electrode wiring is imbedded
in the clamp, this design allows for subject and practitioner
blinding [48].
Validation/Application. In an early double-blinded validation
study on TENS-naive chronic low back pain patients, real
TENS was compared to sham TENS.The results showed that
every patient in the real TENS group believed the unit was
functioning correctly with varying degrees of certainty. In
the sham TENS group, 84% patients believed they have a
functioning unit, with significant lower certainty level [49].
Several subsequent clinical trials have employed placebo
TENS to investigate the efficacy of verum TENS. In a study
of chronic back pain, a 2 × 2 factorial design was used to
compare TENS, placebo TENS, exercise, and no exercise. No
superior benefit was found for verum TENS over placebo
TENS using a VAS of pain ratings and other clinical outcome
measures [50].
In another study, verum TENS versus placebo TENS was
studied in patients with multiple sclerosis and chronic low
back pain. After correcting for multiple comparisons, there
were no significant differences on pain visual analog scale and
other self-evaluation scales between the verum and placebo
TENS groups [51].
In one study, investigators studied the efficacy of TENS
compared to placebo TENS and a control no-treatment
group in a population of patients with chronic low back
pain. Average pain ratings collected immediately before and
after each treatment demonstrated a significant reduction
in pain in both the verum and placebo TENS groups. Pain
intensity was reduced significantly more for those in the
TENS group compared to the placebo TENS group. Addi-
tionally, investigators studied the additive effects of 10-week
treatment (administered twice weekly) and found that TENS
but not placebo TENS demonstrated a reduction in pain
intensity over the first 16 treatments. Similarly, verum TENS
was more effective than placebo TENS in maintaining pain
reduction one week after the last treatment. The benefit in
pain reduction continued for 3 and 6months after completion
of the study regardless of whether subjects received verum
or placebo TENS treatment. The no-treatment control con-
dition, in contrast, demonstrated no natural improvement in
pain over the same course of time [52].
2.2.2. Laser Acupuncture
Description. Laser acupuncture is defined as the stimulation
of traditional acupuncture points with low-intensity, non-
thermal laser irradiation. Verum laser acupuncture produces
a wavelength of infrared laser light. Both verum and placebo
laser acupuncture are manufactured with visual red light and
acoustic signal.
Validation/Application. In 2001, Irnich and colleagues [53]
were the first investigators to adopt the placebo laser
acupuncture device. They used placebo laser acupuncture
as the inert control in a study that compared conventional
massage with acupuncture (verum needle and placebo laser
acupunctures) for the treatment of chronic neck pain. The
placebo laser acupuncture was performed with an inactive
laser pen, which produced a red light with no infrared
properties. The results from this study suggest that needle
acupuncture is significantly more effective than massage and
equally as effective as a short-term treatment for patients with
chronic neck pain, indicating that placebo laser acupuncture
might share some of the same nonspecific effects with needle
acupuncture.
The validity of the placebo laser acupuncture as a general
acupuncture control was thoroughly discussed in an article
written by Irnich et al. [54]. In another study they also inves-
tigated the validity of the placebo laser acupuncture device
as a laser acupuncture control. The results of this random-
ized, double-blind crossover study suggested that placebo
laser acupuncture produces the same nonspecific effects as
laser acupuncture. Additionally, there were no significant
differences between the efficacy ratings of acupuncture-
experienced and acupuncture-naive subjects in this study.
Neither the subject nor the treating acupuncturists were able
to distinguish between the real and placebo laser devices.
Over the years, this device has been applied in several trials
to treat diseases such as acute tonsillitis, and pharyngitis,
vasomotor rhinitis and whiplash injuries [55–58].
3. Discussion
Finding a proper control remains a primary methodological
concern in acupuncture research. Traditionally, two main
categories of acupuncture control have existed: (1) sham
acupuncture, which involves the use of real needles that
puncture the skin and (2) placebo acupuncture, which is non-
penetrating. Sham acupuncture utilizes penetrating needles
that are either applied fully to nonacupoints or shallowly
to acupoints or both [8]. But the problem is that it can
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Table 1: Considerations for use of placebo devices in acupuncture research.
Types of device
Considerations
Visually
indistinguishable
Somato-
sensation
Constraint
of needle
insertion
Commercial
availability
Self-
made
Modality
specific Price Reusable
Appropriate
for
double-blind
study design
Appropriate
for crossover
study design
Blunted needles
devices
The Steitberger
device √ √ √
$6.3 per
needle
The Park
device √ √ √ √
$2.9 per
needle
The Japanese
device √ √ √ NA √
Foam device √ √ √ NA √
Others √ √ NA √
Nonneedle
devices
Placebo TENS √ NA √ √
$59 to
$260 per
unit
√ √ √
Placebo laser
acupuncture √ √ NA √ √
$hundred
to
thousand
per unit
√ √ √
Prices according to Google Shopping. The actual prices may vary across vendors.
be difficult to find a noninfluential site on the skin that is
not near other acupoint, and shallow needling can resemble
some traditional Chinese acupuncture techniques. Several
studies, however, have indicated that sham acupuncture can
also produce a therapeutic response and elicit neurobiological
responses at various levels in the central nervous system
[59].
Thus, a placebo acupuncture device may be a more
appropriate control for verum acupuncture because it min-
imizes the physiologic response and is relatively inert. In this
paper, we have described a range of placebo acupuncture
devices currently used in acupuncture research. Table 1 lists
the relative advantages and disadvantages of the devices, as
well as the common and unique aspects of the devices as
discussed below.With this table, we seek to highlight some of
the considerations investigators should take when designing
their placebo-controlled acupuncture studies.
Placebo acupuncture is generally noninvasive. The
blunted needles used in these devices are relatively inert
and indistinguishable from real acupuncture needles. The
Streitberger, Park, and Japanese devices are three of the
most commonly used placebo needle devices in acupuncture
research. The Japanese device is the only needling device
that can be employed in double-blinded trials. All three of
these devices are used in a similar manner; a blunted needle
is inserted, touches the skin, and is retracted. These three
devices, while standardized and validated, are not widely
available for researchers worldwide since they are custom
fabricated. Aside from the Streitberger device, all other
placebo devices have physical limitations with regard to their
ability to facilitate a range of manipulation methods, such as
shallow or horizontal insertion. They are also not effective
for all acupoint types and acupuncture positions. The foam
device, simple toothpick, and blunted needle device are
not standardized and thus cannot be validated. Since these
devices have not been validated, the quality of the results
from RCTs using these devices remains unconfirmed.
All placebo needle devices involve contact with the skin.
Physical contact with the surface of the skin may provide
sensory stimulation, indicating that even blunted needle
devices are not entirely inert and may elicit a therapeutic
effect of their own. For instance, Han and Lund et al. noted
that the sensation produced by a needle tip “touch” was
substantial [60] and it may activate parts of the peripheral
nervous system [61]. Thus, using blunted needle devices on
nonacupoints in acupuncture studiesmightmake the placebo
acupuncture relatively inert.
The response to placebo acupuncture treatment is due to
a variety of factors, including the presence or absence of deqi
sensations. The deqi phenomenon is a complex set of phys-
iological sensations associated with acupuncture treatment
[14, 62]. Those who have experienced acupuncture deqi sen-
sations prior to treatment are often cognizant of the absence
of deqi when they receive placebo acupuncture treatment.
For instance, in one single-blind randomized, crossover pilot
study [63] that involved patients with chronic pain receiving
both verum and placebo acupuncture treatment, subjects
who received the placebo treatment first thought that they
were receiving verum treatment after one single treatment.
However, after the second treatment, nearly 40% of those
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same subjects were able to detect a difference between the
two needles. Thus, it is also important to measure the deqi
sensation in acupuncture clinical trials even when sham
devices are applied. In light of this finding, some investigators
[46] choose to exclude patients with previous acupuncture
experience.
Similar to other longitudinal treatment studies involving
placebo treatments, maintaining patient’s blinding through-
out a treatment study involving multiple acupuncture treat-
ments can be difficult. All blunted needle placebo acupunc-
ture devices can be useful in short-term, acute intervention
trials. However, in conditions requiring long-term treatment,
maintaining patient’s blinding may be difficult due to the
subjects’ natural curiosity and/or motivation to learn more
about the type of treatment they have been receiving, which
can lead to unblinding (e.g., patients may talk to each other,
read about acupuncture, or go to another acupuncturist). It
is important for investigators to assess whether or not the
subject blinding can be maintained through the end of the
study.
Unlike verum acupuncture, some placebo devices require
tape or foam for successful application of the placebo treat-
ment. Devices that require tape or foam may induce allergic
reactions and thus may not be tolerated by all subjects. In
addition, there is risk of infection if the needle were to be
inserted through the tape and thus it is necessary to use sterile
techniques. Additionally, these devices may not be suitable
for all acupoints, such as points on the scalp, fingers, and toes
that cannot provide a flat surface for tape or foam.
“Nonneedle” placebo acupuncture devices (TENS and
laser acupuncture) have their own set of common con-
siderations. Neither placebo TENS nor laser acupuncture
provide repeated needle stimulation of the skin and thus are
relatively physiologically inert. Nonneedle placebo devices
are also effective for both acupuncture-experienced and
acupuncture-naive subjects. The major disadvantage of non-
needle devices like TENS and laser acupuncture is that they
differ from verum needle acupuncture in design and concept,
aswell as in context and culture.Therefore, placeboTENS and
placebo laser acupuncturemay only be considered to serve as
valid placebo controls inTENS and laser acupuncture studies,
respectively.
Finally, we would like to emphasize that this paper is
developed to aid investigators in designing studies that test
and explore the efficacy and mechanism of acupuncture and
to facilitate the selection of appropriate acupuncture placebo
devices. The most appropriate placebo acupuncture devices
are those that are the most indistinguishable and inert in
consideration of the specific design on the study.
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